Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy

Treatment of chronic hepatitis C genotype 1 early responders with 36 week pegylated interferon and ribavirin therapy

Introduction. Standard treatment for patients with chronic hepatitis C genotype 1 (CHC G-1) infection includes pegylated interferon plus ribavirin (PEG-RBV) for 48 weeks. Shorter treatment regimen would be more acceptable due to lower cost and fewer side-effects. We aimed to compare the efficacy of...

Full description

Bibliographic Details
Main Authors: Ajit Sood, M.D., D.M., Vandana Midha, Omesh Goyal
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Annals of Hepatology
Subjects:
Early virological response
Shorter therapy
Sustained virological response
Thirty-six weeks
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119312499

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119312499

Similar Items